Insights

Precision Oncology Focus Prelude Therapeutics is a precision oncology company with a pipeline of innovative drug candidates targeting critical cancer cell pathways, presenting opportunities for collaboration in the oncology space.

Partnership Expansion Recent partnerships with Device Authority, Aquaculture Technologies, AbCellera, and BeiGene showcase Prelude's commitment to collaboration, indicating potential avenues for joint ventures and business development opportunities.

Financial Health With funding of $448M and revenue in the range of $10M - 50M, Prelude's stable financial position creates potential sales opportunities for suppliers, service providers, and investors looking to engage with a financially robust biotech company.

Strategic Pipeline Progress Prelude's strategic pipeline progress, especially in developing precision antibody drug conjugates and clinical trial collaborations, underscores opportunities for companies in the pharmaceutical and biotech sectors to explore synergistic partnerships.

Market Expansion Prelude Therapeutics' expansion into developing cancer drugs and exploring new treatments indicates potential opportunities for market expansion, licensing agreements, and investment deals in the rapidly evolving biotechnology landscape.

Prelude Therapeutics Tech Stack

Prelude Therapeutics uses 8 technology products and services including WordPress, Hyperion, Microsoft, and more. Explore Prelude Therapeutics's tech stack below.

  • WordPress
    Content Management System
  • Hyperion
    Corporate Performance Management
  • Microsoft
    Miscellaneous
  • Office 365
    Office Suites
  • X-XSS-Protection
    Security
  • HSTS
    Security
  • FedEx
    Transportation And Fleet Management
  • Minitab
    Visualisation Software

Media & News

Prelude Therapeutics's Email Address Formats

Prelude Therapeutics uses at least 1 format(s):
Prelude Therapeutics Email FormatsExamplePercentage
flast@preludetx.comJDoe@preludetx.com
94%
last@preludetx.comDoe@preludetx.com
4%
fl@preludetx.comJD@preludetx.com
1%
middle@preludetx.comMichael@preludetx.com
1%

Frequently Asked Questions

Where is Prelude Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Prelude Therapeutics's main headquarters is located at 175 Innovation Boulevard Wilmington, DE 19805 US. The company has employees across 2 continents, including North AmericaEurope.

What is Prelude Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Prelude Therapeutics's main corporate office by phone at +1-302-547-3768. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Prelude Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Prelude Therapeutics is a publicly traded company; the company's stock symbol is PRLD.

What is Prelude Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Prelude Therapeutics's official website is preludetx.com and has social profiles on LinkedIn.

How much revenue does Prelude Therapeutics generate?

Minus sign iconPlus sign icon
As of May 2024, Prelude Therapeutics's annual revenue reached $15M.

What is Prelude Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Prelude Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Prelude Therapeutics have currently?

Minus sign iconPlus sign icon
As of May 2024, Prelude Therapeutics has approximately 138 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer And Founder: K. V.Chief Legal Officer And Interim Cfo: B. L.Chief Financial Officer: L. C.. Explore Prelude Therapeutics's employee directory with LeadIQ.

What industry does Prelude Therapeutics belong to?

Minus sign iconPlus sign icon
Prelude Therapeutics operates in the Biotechnology Research industry.

What technology does Prelude Therapeutics use?

Minus sign iconPlus sign icon
Prelude Therapeutics's tech stack includes WordPressHyperionMicrosoftOffice 365X-XSS-ProtectionHSTSFedExMinitab.

What is Prelude Therapeutics's email format?

Minus sign iconPlus sign icon
Prelude Therapeutics's email format typically follows the pattern of . Find more Prelude Therapeutics email formats with LeadIQ.

How much funding has Prelude Therapeutics raised to date?

Minus sign iconPlus sign icon
As of May 2024, Prelude Therapeutics has raised $448M in funding. The last funding round occurred on Sep 15, 2021 for $5.5M.

When was Prelude Therapeutics founded?

Minus sign iconPlus sign icon
Prelude Therapeutics was founded in 2016.
Prelude Therapeutics

Prelude Therapeutics

Biotechnology ResearchDelaware, United States51-200 Employees

Prelude Therapeutics is a clinical-stage precision oncology company developing innovative drug candidates targeting critical cancer cell pathways. The Company’s diverse pipeline is comprised of highly differentiated, potentially best-in-class proprietary small molecule compounds aimed at addressing clinically validated pathways for cancers with selectable underserved patients. Prelude’s pipeline includes three candidates currently in clinical development: PRT3789 an IV administered, potent and highly selective SMARCA2 degrader, PRT2527, a potent and highly selective CDK9 inhibitor, PRT3645 a next generation CDK4/6 inhibitor, and a preclinical oral candidate targeting SMARCA2.

Section iconCompany Overview

Headquarters
175 Innovation Boulevard Wilmington, DE 19805 US
Phone number
+1-302-547-3768
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRLD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $448M

    Prelude Therapeutics has raised a total of $448M of funding over 6 rounds. Their latest funding round was raised on Sep 15, 2021 in the amount of $5.5Mas a state taxpayer-backed grants.

  • $10M$50M

    Prelude Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $448M

    Prelude Therapeutics has raised a total of $448M of funding over 6 rounds. Their latest funding round was raised on Sep 15, 2021 in the amount of $5.5Mas a state taxpayer-backed grants.

  • $10M$50M

    Prelude Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.